We think that those experiments correspond to an established mutator phenotype [29] and, thus, to the carcinogenic process in humans who have strong cancer susceptibility traits such as Li-Fraumeni syndrome (p53) [30] or melanoma kindreds (p16) [31]. The gene discussed is CDKN2A; the disease is Li-Fraumeni syndrome.